FDA approval opens new chapter in pancreatic cancer treatment

For decades, a diagnosis of metastatic pancreatic cancer left patients and physicians facing the same harsh reality: limited options, difficult treatments and too little time. Now, a pill tested in a global clinical trial ...

page 1 from 40